Viking Therapeutics, Inc. (VKTX)

32.14 +0.21 (+0.66%) USD  |  NASDAQ  |  Mar 04, 16:00
31.98 -0.16 (-0.50%) Pre-Market: 08:13
More

Viking Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Hims & Hers Health, Inc. Upgrade
Altimmune, Inc. Upgrade